Natasha Kekre profile picture

Contact Information

Natasha Kekre, BSc, MD, MPH, FRCPC
6137378899 x.71064
nkekre@toh.on.ca

501 Smyth Road
CPCR Box 201A
Ottawa, ON
K1H 8L6

Publications

Selected Publications

1: Kekre N, Marquez-Malaver FJ, Cabrero M, Piñana J, Esquirol A, Soiffer RJ, Caballero D, Terol MJ, Martino R, Antin JH, Corral LL, Solano C, Armand P, Perez-Simon JA. Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients undergoing Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma. Biol Blood Marrow Transplant. 2016 Jul 25. pii: S1083-8791(16)30222-1. doi: 10.1016/j.bbmt.2016.07.006.


2: Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014 Jul 17;124(3):334-43.

3: Kekre N, Mak KS, Stopsack KH, Binder M, Ishii K, Brånvall E, Cutler CS. Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis. Am J Hematol. 2016 Jun;91(6):551-5.

4: Kekre N, Kim HT, Thanarajasingam G, Armand P, Antin JH, Cutler C, Nikiforow S, Ho VT, Koreth J, Alyea EP, Soiffer RJ. Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation. Haematologica. 2015 Sep;100(9):1222-7.

5: Kekre N, Tokessy M, Mallick R, McDiarmid S, Huebsch L, Bredeson C, Allan D, Tay J, Tinmouth A, Sheppard D. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal  leukoreduction? Biol Blood Marrow Transplant. 2013 Dec;19(12):1719-24.

Listings from The Ottawa Hospital Library

This lists the 20 most recent publications in The Ottawa Hospital's Library database from this researcher.This database only starts tracking a researcher's publications once they start working at the Ottawa Hospital Research Institute.

Visram, A; Bredeson, C; Allan, D; Sabloff, M; Huebsch, L; Tay, J; Kekre, N; McDiarmid, S; Mallick, R; Tinmouth, A; Martin, L; Hamelin, L; Maze, D, 2018 1/29/2018, Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers, BLOOD CANCER JOURNAL, 8

Kekre, N; Antin, JH, 2017 3/28/2018, ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint, BLOOD ADVANCES, 9, 573-576

Bryant, A; Mallick, R; Huebsch, L; Allan, D; Atkins, H; Anstee, G; Sabloff, M; Scrivens, N; Maze, D; Bredeson, C; Kekre, N, 2017, Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23, 12, 2096-2101 ➤ view abstract

Grigor, EJM; Fergusson, DA; Haggar, F; Kekre, N; Atkins, H; Shorr, R; Holt, RA; Hutton, B; Ramsay, T; Seftel, M; Jonker, D; Daugaard, M; Thavorn, K; Presseau, J; Lalu, MM, 2017, Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis, BMJ OPEN, 7, 12 ➤ view abstract

Kekre, N; Zhang, Y; Zhang, MJ; Carreras, J; Ahmed, P; Anderlini, P; Atta, EH; Ayas, M; Boelens, JJ; Bonfim, C; Deeg, HJ; Kapoor, N; Lee, JW; Nakamura, R; Pulsipher, MA; Eapen, M; Antin, JH, 2017, Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia, HAEMATOLOGICA, 7, 1291-1298 ➤ view abstract

Kekre, N; Kim, HT; Ho, VT; Cutler, C; Armand, P; Nikiforow, S; Alyea, EP; Soiffer, RJ; Antin, JH; Connors, JM; Koreth, J, 2017, Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation, HAEMATOLOGICA, 7, 1185-1191 ➤ view abstract

Kekre, N; Marquez-Malaver, FJ; Cabrero, M; Pinana, J; Esquirol, A; Soiffer, RJ; Caballero, D; Terol, MJ; Martino, R; Antin, JH; Lopez-Corral, L; Solano, C; Armand, P; Perez-Simon, JA, 2016, Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, 10, 1808-1815 ➤ view abstract

Kekre, N; Antin, JH, 2016, Emerging drugs for graft-versus-host disease, EXPERT OPINION ON EMERGING DRUGS, 2, 209-218 ➤ view abstract

Kekre, N; Antin, JH, 2016, Cord blood versus haploidentical stem cell transplantation for hematological malignancies, SEMINARS IN HEMATOLOGY, 53, 2, 98-102 ➤ view abstract

Kekre, N; Mak, KS; Stopsack, KH; Binder, M; Ishii, K; Branvall, E; Cutler, CS, 2016, Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis, AMERICAN JOURNAL OF HEMATOLOGY, 91, 6, 551-555 ➤ view abstract

Rizk, M; Monaghan, M; Shorr, R; Kekre, N; Bredeson, CN; Allan, DS, 2016, Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, 8, 1416-1423 ➤ view abstract

Christou, G; Kekre, N; Petrcich, W; Tokessy, M; Neurath, D; Giulivi, A; Saidenberg, E; McDiarmid, S; Atkins, H; Bence-Bruckler, I; Bredeson, C; Huebsch, L; Sabloff, M; Sheppard, D; Tay, J; Tinmouth, A; Allan, DS, 2015, Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation, TRANSFUSION, 55, 2, 253-258 ➤ view abstract

Kekre, N; Mallick, R; Allan, D; Tinmouth, A; Tay, J, 2013 7/16/2018, The Impact of Prolonged Storage of Red Blood Cells on Cancer Survival, PLOS ONE, 8, 7 ➤ view abstract

Kekre, N; Philippe, J; Mallick, R; Smith, S; Allan, D, 2013, Modelling Improvements in Cell Yield of Banked Umbilical Cord Blood and the Impact on Availability of Donor Units for Transplantation into Adults, STEM CELLS INTERNATIONALview abstract

Kekre, N; Tokessy, M; Mallick, R; McDiarmid, S; Huebschl, L; Bredeson, C; Allan, D; Tay, J; Tinmouth, A; Sheppard, D, 2013, Is Cytomegalovirus Testing of Blood Products Still Needed for Hematopoietic Stem Cell Transplant Recipients in the Era of Universal Leukoreduction?, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 12, 1719-1724 ➤ view abstract

Kekre, N; Djordjevic, B; Touchie, C, 2012 5/15/2018, Spontaneous tumour lysis syndrome, CANADIAN MEDICAL ASSOCIATION JOURNAL, 8, 913-916

Kekre, N; Christou, G; Mallick, R; Tokessy, M; Tinmouth, A; Tay, J; Allan, DS, 2012, Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation, TRANSFUSION, 9, 2049-2054 ➤ view abstract

Fralick, M; Bouganim, N; Kremer, R; Kekre, N; Robertson, S; Vandermeer, L; Kuchuk, I; Li, J; Murshed, M; Clemons, M, 2012, Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results, JOURNAL OF BONE ONCOLOGY, 1, 3, 69-73 ➤ view abstract

Kekre, N; Chou, A; Tokessey, M; Doucette, S; Tinmouth, A; Tay, J; Allan, DS, 2011, Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation, TRANSFUSION, 11, 2488-2494 ➤ view abstract

Rodger, MA; Kekre, N; Le Gal, G; Kahn, SR; Wells, PS; Anderson, DA; Chagnon, I; Solymoss, S; Crowther, M; Perrier, A; White, R; Vickars, L; Ramsay, T; Betancourt, MT; Kovacs, MJ, 2011, Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism, BRITISH JOURNAL OF HAEMATOLOGY, 4, 511-513

More publications may be available in The Ottawa Hospital Library database.